Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016 (2016), Article ID 3240261, 11 pages
http://dx.doi.org/10.1155/2016/3240261
Research Article

On the Anticataractogenic Effects of L-Carnosine: Is It Best Described as an Antioxidant, Metal-Chelating Agent or Glycation Inhibitor?

1Faculty of Science, Engineering and Computing, Kingston University London, Penrhyn Road, Kingston upon Thames KT1 2EE, UK
2Department of Pharmaceutics, Faculty of Pharmacy, Minia University, Minia, Egypt
3School of Pharmacy, The University of Auckland, Auckland, New Zealand

Received 11 April 2016; Revised 9 August 2016; Accepted 29 August 2016

Academic Editor: Janusz Gebicki

Copyright © 2016 Hamdy Abdelkader et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Hamdy Abdelkader, Michael Longman, Raid G. Alany, and Barbara Pierscionek, “On the Anticataractogenic Effects of L-Carnosine: Is It Best Described as an Antioxidant, Metal-Chelating Agent or Glycation Inhibitor?,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 3240261, 11 pages, 2016. doi:10.1155/2016/3240261